Download PDF
Nuklearmedizin 1994; 33(04): 132-137
DOI: 10.1055/s-0038-1629807
Original Article
Schattauer GmbH

Kernspintomographie zum Metastasen-Screening? Ein prospektiver Vergleich mit der Skelettszintigraphie[*]

Magnetic Resonance Imaging in Screening for Bone Metastases? A Prospective Comparison with Bone Scintigraphy
P. Theissen
1   Aus den Kliniken und Polikliniken für Nuklearmedizin (Dir.: Prof. Dr. H. Schicha)
,
K. Smolarz
1   Aus den Kliniken und Polikliniken für Nuklearmedizin (Dir.: Prof. Dr. H. Schicha)
,
A. Scharl
2   Gynäkologie und Geburtshilfe (Dir.: Prof. Dr. A. Bolte) und Universität zu Köln, FRG
,
A. Groth
3   Dermatologie und Venerologie (Dir.: Prof. Dr. T. Krieg), Universität zu Köln, FRG
,
K. Scheidhauer
1   Aus den Kliniken und Polikliniken für Nuklearmedizin (Dir.: Prof. Dr. H. Schicha)
,
E. Voth
1   Aus den Kliniken und Polikliniken für Nuklearmedizin (Dir.: Prof. Dr. H. Schicha)
,
H. Schicha
1   Aus den Kliniken und Polikliniken für Nuklearmedizin (Dir.: Prof. Dr. H. Schicha)
› Author Affiliations
Further Information

Publication History

Eingegangen: 22 January 1994

in revidierter Form: 13 February 1994

Publication Date:
05 February 2018 (online)

    Permissions and Reprints

Zusammenfassung

Bei 102 Patienten mit Tumoren mit häufiger Skelettmetastasierung, wurde im Vergleich zur Skelettszintigraphie (SkSz) der Stellenwert der Kernspintomographie (KST) von Wirbelsäule, Becken, Femora und proximalen Tibiae zum Metastasen-Screening geprüft. Alle Patienten hatten in der SkSz keinen Metastasen-Hinweis, 96 (94%) auch bei der KST. Nur bei 6% der Patienten fanden sich mit KST im Knochenmark Herdbefunde. Dies bedeutet, daß eine 94%ige Wahrscheinlichkeit auf Metastasenfreiheit gegeben ist, wenn die SkSz normal ausfällt, weshalb sie nach wie vor die Methode der Wahl zum Screening nach ossären Metastasen ist. Trotz hoher Sensitivität und Spezifität kann die KST mit der momentanen Routinetechnik die SkSz derzeit wegen längerer Untersuchungszeiten, höherer Kosten und fehlender Ganzkörperaufnahme noch nicht ersetzen, erscheint aber bei radiologisch negativen fraglichen Befunden der SkSz indiziert.

Summary

To define the value of magnetic resonance imaging (MRI) in screening for bone metastases (BM) compared to bone scintigraphy (BSc) 102 patients with tumours with frequent BM were examined also by MRI of spine, plevis, femora, and proximal tibiae. All patients had normal BSc and 96 (94%) normal MRI. Only 6% of the patients had focal abnormalities within the bone marrow. This indicates that there is a 94% probability of absence of BM if BSc is normal. Therefore, BSc should currently remain the method of choice for screening for BM. Despite MRI is sensitive and specific, with the common technique up to now it should not be used instead of BSc in screening because of costs, duration, and lack of whole body examination. MRI is a valuable adjunct in equivocal findings in BSc with negative results on radiographs.

Schlüsselwörter

Skelettmetastasen - Kernspintomographie - Magnetresonanztomographie - Skelettszintigraphie - Knochenmark - Screening

Key words

Bone metastases - magnetic resonance imaging - bone scintigraphy - bone marrow - screening

* Herrn Prof. Dr. med. D. Emrich zum 65. Geburtstag


 

  • Literatur

  • 1 Abrains HL, Spiro R, Goldstein N. Metastases in Carcinoma: analysis of 1000 autopsied cases. Cancer 1950; 3: 336-40.
    CrossrefGoogle Scholar
  • 2 Algra PR, Bloem JL, Tissing H. et al. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 1991; 11: 219-32.
    CrossrefPubMedGoogle Scholar
  • 3 Avrahami E, Radmor R, Dally O, Hadar H. Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scan. J Comput Assist Tomogr 1989; 13: 598-602.
    CrossrefPubMedGoogle Scholar
  • 4 Bauer R, van de Fliert E, Langhammer HR, All-gayer B, Stepan R. Szintigraphie und Kernspintomographie des Skeletts und Knochenmarks. Der Nuklearmediziner 1989; 5: 303-20.
    Google Scholar
  • 5 Berger U, Bettelheim R, Mansi J. et al. The relationship between micrometastases of the bone marrow, histopathologic features of the primary tumour in breast cancer and prognosis. Am Clin Pathol 1988; 12: 333.
    Google Scholar
  • 6 Berrettoni BA, Carter JR. Current concepts review. Mechanisms of cancer metastasis to bone. J Bone Joint Surg [Am] 1986; 68: 308-12.
    CrossrefPubMedGoogle Scholar
  • 7 Bohndorf K. Knochenmetastasen. In: MR Tomographie des Skeletts und der peripheren Weichteile. Bohndorf K. ed. Berlin, Heidelberg. New York: Springer; 1991: 71-4.
    Google Scholar
  • 8 Daffner RH, Lupetin AR, Dash N. et al. MRI in the detection of malignant infiltration of bone marrow. Am J Radiol 1986; 146: 353-8.
    Google Scholar
  • 9 Dearnaley DP, Ormerod MC, Sloane JP. et al. Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J Roy Soc Med 1983; 76: 359.
    CrossrefPubMedGoogle Scholar
  • 10 Duncker CM, Carrio I, Berna L. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 1990; 31: 1450-5.
    PubMedGoogle Scholar
  • 11 Frank JA, Ling A, Patronas NJ. Detection of malignant bone tumors: MR imaging versus scintigraphy. Am J Radiol 1990; 155: 1043.
    Google Scholar
  • 12 Haubold-Reuter BG, Duewell S, Schilcher B, Marcincek B, von Schulthess GK. The value of bone scintigraphy, bone marrow scintigraphy and fast spinecho magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study. Eur J Nucl Med 1993; 20: 1063-9.
    PubMedGoogle Scholar
  • 13 Hirsch FR, Hansen HH. Bone marrow involvement in small cell anaplastic carcinoma of the lung. Cancer 1988; 46: 206-11.
    Google Scholar
  • 14 Hotze A, Ruhlmann J, Bockisch A, Briele B, Bier-sack J. Vergleich der Knochenmarkszintigraphie und Magnetresonanztomographie beim Plas-mocytom. Der Nuklearmediziner 1989; 5: 337-41.
    Google Scholar
  • 15 Ihde DC, Simms B, Matthews MJ. et al. Bone marrow metastases of small cell carcinoma of the lung: frequency, description, and influence on che-motherapeutic toxicity and prognosis. Blood 1979; 53: 677-86.
    PubMedGoogle Scholar
  • 16 Jelinek JS, Redmond III J, Perry JJ. et al. Small cell lung cancer: staging with MR imaging. Radiology 1990; 177: 837-42.
    CrossrefPubMedGoogle Scholar
  • 17 Jones Al, Williams MP, Powles TJ. et al. Magnetic resonance imaging in detection of skeletal metastases in patients with breast cancer. Br J Cancer 1990; 62: 296-8.
    CrossrefPubMedGoogle Scholar
  • 18 Kamby C, Guldhammer B, Vejborg I. et al. The presence of tumour cells in bone marrow at the time of first recurrence of breast cancer. Cancer 1987; 60: 1306.
    CrossrefPubMedGoogle Scholar
  • 19 Kattapuram SV, Khurana JS, Scott JA, El-Khoury GY. Negative scintigraphy with positive magnetic resonance imaging in bone metastases. Skeletal Radiol 1990; 19: 113-6.
    PubMedGoogle Scholar
  • 20 Krishnamurthy GT, Tubis M, Hiss J, Blahd WH. Distribution pattern of metastatic bone disease: a need for total body skeletal imaging. J Am Med Ass 1977; 237: 2504-6.
    CrossrefGoogle Scholar
  • 21 Landys K. Prognostic value of bone marrow biopsy in breast cancer. Cancer 1982; 49: 513.
    CrossrefPubMedGoogle Scholar
  • 22 Layer G, Jarosch K. Magnetresonanztomographie des Knochenmarks zum Nachweis von Metastasen solider Tumoren. Radiologe 1992; 32: 502-8.
    PubMedGoogle Scholar
  • 23 Devithan N, Byrne RE, Bromer RN. et al. The value of the bone scan and bone marrow biopsy in staging small cell lung cancer. Cancer 1985; 56: 652.
    CrossrefPubMedGoogle Scholar
  • 24 Linden A, Zankovich R, Theissen P, Diehl V, Schicha H. Malignant lymphoma: bone marrow imaging versus biopsy. Radiology 1989; 173: 335.
    CrossrefPubMedGoogle Scholar
  • 25 Mansi JL, Berger U, McDonnel T. et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 1989; 7: 445.
    CrossrefPubMedGoogle Scholar
  • 26 McKillop JH. Bone scanning in metastatic disease. In: Bone scanning in clinical practice. Fogelman I. ed. Berlin, Heidelberg, New York: Springer; 1987: 41-60.
    CrossrefGoogle Scholar
  • 27 McKillop JH. Bone scanning in primary bone tumours and marrow disorders. In: Bone scanning in clinical practice. Fogelman I. ed. Berlin, Heidelberg, New York: Springer; 1987: 61-72.
    CrossrefGoogle Scholar
  • 28 McNeil BJ. Value of bone scanning in neoplastic disease. Semin Nucl Med 1984; 14: 277-86.
    CrossrefPubMedGoogle Scholar
  • 29 Meinshausen J, Choritz H, Georgi A. Frequency of skeletal metastases as revealed by routinely taken bone marrow biopsies. Virchows Arch [A] 1980; 389: 409.
    CrossrefPubMedGoogle Scholar
  • 30 Otsuika N, Fugunaka M, Sone T. et al. The usefulness of bone marrow scintigraphy in the detection of bone metastases from prostatic cancer. Eur J Nucl Med 1985; 11: 319-22.
    CrossrefPubMedGoogle Scholar
  • 31 Pantel K, lzbicki JR, Angstwurm M. et al. lmmuno-cytological detection of bone marrow micrometastases in operable non small cell lung cancer. Cancer Res 1993; 33: 1027-31.
    Google Scholar
  • 32 Porter BA, Shields AF, Olson DO. Magnetic resonance imaging of bone marrow disorders. Radiol Clin N Am 1986; 24: 269-89.
    PubMedGoogle Scholar
  • 33 Redding HW, Coombes RC, Monaghan P. et al. Detection of micrometastases in patients with primary breast cancer. Lancet 1983; ii: 1271.
    PubMedGoogle Scholar
  • 34 Reske SN, Karstens HJ, Glöckner W, Schwarz A, Steinstässer A, Ammon J, Buell U. Radioimmuno-imaging of bone marrow. Results in patients with breast cancer and skeletal metastases and patients with malignant lymphomas 1989; II: 299.
    Google Scholar
  • 35 Reske SN. Recent advances in bone marrow scanning. Eur J Nucl Med 1991; 18: 203-21.
    CrossrefPubMedGoogle Scholar
  • 36 Ridell B, Landys K. Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest. Cancer 1979; 44: 1782.
    CrossrefPubMedGoogle Scholar
  • 37 Rieden K. Knochenmetastasen. Berlin, Heidelberg, New York: Springer; 1988
    Google Scholar
  • 38 Scher HI, Yagoda A. Bone metastases: pathogenesis, treatment and rationale for the use of resorption inhibitors. Am J Med 1987; 82 (Suppl 2 A): 6.
    CrossrefPubMedGoogle Scholar
  • 39 Schlimok G, Funke L, Holzmann B. Micrometasta-tic cancer cells in bone marrow at the time of first recurrence: in vitro detection with anticytokeratin and in vivo labelling with anti-17-lA monoclonal antibodies. Proc Natl Acad Sei 1987; 84: 8672.
    CrossrefPubMedGoogle Scholar
  • 40 Smolarz K, Jungehülsing M, Krug B. et al. Kernspintomographie des Knochenmarks bei Karzi-nompa-tienten mit einer solitären Mehranreicherung im Skelettszintigramm. Nucl-Med 1990; 29: 269-73.
    Google Scholar
  • 41 Soudah B, Stauch G, Sprindler B, Nicolai U, Geor-gii A. Histologischer Tumortyp und Knochenmarksmetastasen von Carcinomen der Brustdrüse. Verh Dtsch Ges Pathol 1985; 69: 338.
    PubMedGoogle Scholar